The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity

Diabetes

Volumn 62, Issue 4, 2013, Pages 1102-1108

  Coomans, Claudia P ^a   Van Den Berg, Sjoerd A A ^a   Lucassen, Eliane A ^a   Houben, Thijs ^a   Pronk, Amanda C M ^a   Van Der Spek, Rianne D ^b   Kalsbeek, Andries ^b,c   Biermasz, Nienke R ^a   Van Dijk, Ko Willems ^a   Romijn, Johannes A ^a,b   Meijer, Johanna H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE COURSE; ENERGY BALANCE; ENERGY METABOLISM; FAT MASS; FOOD INTAKE; GLUCONEOGENESIS; HYPERINSULINEMIA; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; CALORIMETRY, INDIRECT; CIRCADIAN RHYTHM; ENERGY METABOLISM; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; SUPRACHIASMATIC NUCLEUS;

EID: 84875462519     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0507     Document Type: Article

References (50)

1. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008;9:764-775
2. Yamazaki S, Numano R, Abe M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000;288:682-685
3. Davidson AJ, Yamazaki S, Arble DM, Menaker M, Block GD. Resetting of central and peripheral circadian oscillators in aged rats. Neurobiol Aging 2008;29:471-477
4. Kalsbeek A, Buijs RM. Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting. Cell Tissue Res 2002;309:109-118
5. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418:935-941
6. Cailotto C, La Fleur SE, Van Heijningen C, et al. The suprachiasmatic nucleus controls the daily variation of plasma glucose via the autonomic output to the liver: are the clock genes involved? Eur J Neurosci 2005;22: 2531-2540
7. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997;18:716-738
8. Weibel L, Follenius M, Spiegel K, Ehrhart J, Brandenberger G. Comparative effect of night and daytime sleep on the 24-hour cortisol secretory profile. Sleep 1995;18:549-556
9. Kalra SP, Bagnasco M, Otukonyong EE, Dube MG, Kalra PS. Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul Pept 2003;111:1-11
10. Kalsbeek A, Fliers E, Romijn JA, et al. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 2001;142: 2677-2685
11. Glass JD, Guinn J, Kaur G, Francl JM. On the intrinsic regulation of neuropeptide Y release in the mammalian suprachiasmatic nucleus circadian clock. Eur J Neurosci 2010;31:1117-1126
12. Foster RG, Roenneberg T. Human responses to the geophysical daily, annual and lunar cycles. Curr Biol 2008;18:R784-R794
13. Colwell CS. Linking neural activity and molecular oscillations in the SCN. Nat Rev Neurosci 2011;12:553-569
14. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005;308:1043-1045
15. Nakamura TJ, Nakamura W, Yamazaki S, et al. Age-related decline in circadian output. J Neurosci 2011;31:10201-10205
16. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985; 342:37-44
17. Deboer T, Overeem S, Visser NA, et al. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 2004;129: 727-732
18. Dörrscheidt GJ, Beck L. Advanced methods for evaluating characteristic parameters (T, 7, p) of Circadian Rhythms. J Math Biol 1975;2:107-121
19. van den Berg SA, Guigas B, Bijland S, et al. High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity. Nutr Metab (Lond) 2010;7:24
20. Coomans CP, Biermasz NR, Geerling JJ, et al. Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice. Diabetes 2011;60:3132-3140
21. Kelley DE, Mandarino LJ. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 1990;86:1999-2007
22. Nieuwenhuys R, Voogd J, van Huijzen C. The Human Central Nervous System. Berlin, Springer-Verlag, 2008
23. Sims JS, Lorden JF. Effect of paraventricular nucleus lesions on body weight, food intake and insulin levels. Behav Brain Res 1986;22:265-281
24. Touzani K, Velley L. Ibotenic acid lesion of the hypothalamic paraventricular nucleus produces weight gain but modifies neither preference nor aversion for saccharin. Physiol Behav 1992;52:673-678
25. Pénicaud L, Kinebanyan MF, Ferré P, et al. Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity. Am J Physiol 1989; 257:E255-E260
26. Grundmann SJ, Pankey EA, Cook MM, Wood AL, Rollins BL, King BM. Combination unilateral amygdaloid and ventromedial hypothalamic lesions: evidence for a feeding pathway. Am J Physiol Regul Integr Comp Physiol 2005;288:R702-R707
27. Kageyama A, Hirano T, Kageyama H, et al. Distinct role of adiposity and insulin resistance in glucose intolerance: studies in ventromedial hypothalamic-lesioned obese rats. Metabolism 2002;51:716-723
28. King BM, Phelps GR, Frohman LA. Hypothalamic obesity in female rats in absence of vagally mediated hyperinsulinemia. Am J Physiol 1980;239: E437-E441
29. Gallou-Kabani C, Vigé A, Gross MS, et al. C57BL/6J and A/J mice fed a highfat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 2007;15:1996-2005
30. Schreyer SA, Wilson DL, LeBoeuf RC. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 1998;136: 17-24
31. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS. Reversal of dietinduced obesity and diabetes in C57BL/6J mice. Metabolism 1998;47:1089-1096
32. Harrold JA, Widdowson PS, Clapham JC, Williams G. Individual severity of dietary obesity in unselected Wistar rats: relationship with hyperphagia. Am J Physiol Endocrinol Metab 2000;279:E340-E347
33. Phan Trongha X, Chan GC, Sindreu CB, Eckel-Mahan KL, Storm DR. The diurnal oscillation of MAP (mitogen-activated protein) kinase and adenylyl cyclase activities in the hippocampus depends on the suprachiasmatic nucleus. J Neurosci 2011;31:10640-10647
34. Angeles-Castellanos M, Salgado-Delgado R, Rodriguez K, Buijs RM, Escobar C. The suprachiasmatic nucleus participates in food entrainment: a lesion study. Neuroscience 2010;165:1115-1126
35. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring) 2009;17: 2100-2102
36. Salgado-Delgado R, Angeles-Castellanos M, Saderi N, Buijs RM, Escobar C. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology 2010;151: 1019-1029
37. Bray MS, Tsai JY, Villegas-Montoya C, et al. Time-of-day-dependent dietary fat consumption influences multiple cardiometabolic syndrome parameters in mice. Int J Obes (Lond) 2010;34:1589-1598
38. Fonken LK, Workman JL, Walton JC, et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA 2010;107: 18664-18669
39. Amir S, Shizgal P, Rompré PP. Glutamate injection into the suprachiasmatic nucleus stimulates brown fat thermogenesis in the rat. Brain Res 1989;498:140-144
40. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51:2944-2950
41. Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 2008;16:1025-1032
42. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32(Suppl 3):14-23
43. Boden G, Chen X, Urbain JL. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 1996;45:1044-1050
44. La Fleur SE, Kalsbeek A, Wortel J, Fekkes ML, Buijs RM. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001; 50:1237-1243
45. Ruiter M, Buijs RM, Kalsbeek A. Hormones and the autonomic nervous system are involved in suprachiasmatic nucleus modulation of glucose homeostasis. Curr Diabetes Rev 2006;2:213-226
46. La Fleur SE. Daily rhythms in glucose metabolism: suprachiasmatic nucleus output to peripheral tissue. J Neuroendocrinol 2003;15:315-322
47. Arslanian S, Ohki Y, Becker DJ, Drash AL. Demonstration of a dawn phenomenon in normal adolescents. Horm Res 1990;34:27-32
48. Bolli GB, De Feo P, De Cosmo S, et al. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 1984;33:1150-1153
49. Kalsbeek A, La Fleur S, Van Heijningen C, Buijs RM. Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci 2004;24:7604-7613
50. Rudic RD, McNamara P, Curtis AM, et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004;2:e377